Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Cancer Research Center of Toulouse at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Cancer Research Center of Toulouse brings 2 presentations to ASH 2026 in New Orleans. Its program centres on why leukemia and myeloma cells resist treatment. It covers chemoresistance in acute myeloid leukemia and the natural history of smoldering myeloma.

OrganizationASH 2026 Attendance
Universities & research institutes
Cancer research institute in Toulouse, France, run by Inserm, CNRS and the University of Toulouse.
Session
Fri Dec 11
3:00pm–6:00pm
Scientific Workshop on Mitochondria and Metabolism in Blood Cancer - From Discovery to Patients
Mitochondria and cell metabolism as drivers of blood cancer survival, with practical ways to test metabolic weak points and carry them into trials.
Leukemias · Blood biology
Talk
Sun Dec 13
9:30am–10:45am
Biological Insights into Resistant Cells
Leukemia cells that survive treatment and seed relapse lean on mitochondrial energy production, and their metabolic and surface features could be drug targets.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Cancer Research Center of Toulouse

Tell us what you sell and we’ll find the people at Cancer Research Center of Toulouse most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction